Research for Treatment of Hypertrophic Scars and Keloids using an Intralesional 1470 nm bare-fibre Diode Laser

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038092

Enrollment

Unknown

Registered

2020-09-10

Start date

2017-01-01

Completion date

Unknown

Last updated

2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar

Interventions

Case series:1470nm laser

Eligibility

Sex/Gender

All

Age

3 Years to 66 Years

Inclusion criteria

Inclusion criteria: With a hypertrophic scar or keloid recalcitrant to other therapies with the size of scar more than 10 cm2; caused by burns, trauma, surgery, insect bite or acne.

Exclusion criteria

Exclusion criteria: Patients who had undergone to previous scar therapies such as laser or surgery, had heart or kidney failure, received immunosuppressive drugs or had autoimmune disorders or uncontrolled diabetes, and those who were not able to follow the protocol were excluded.

Design outcomes

Primary

Measure	Time frame
Scar thickness;	—

Secondary

Measure	Time frame
scar firmness;pigmentation;Blood perfusion;	—

Countries

China

Contacts

Public ContactYixin Zhang

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

lkbeley@163.com+86 18817821566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026